The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
API
NEW
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
Dividends
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
API Service
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
API
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
NASDAQ, APVO:
03 Sep 2025
LAST:
1.690
CHANGE:
0.09
OPEN:
1.590
HIGH:
1.730
ASK:
2.880
VOLUME:
122.9K
CHG(%):
5.63
PREV:
1.600
LOW:
1.590
BID:
2.040
CHART
Period:
End of Day
1 Minute
5 Minute
10 Minute
15 Minute
30 Minute
Hourly
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
04 Sep 25
1.690
1.692
1.560
1.630
175.9K
03 Sep 25
1.590
1.730
1.590
1.690
122.9K
02 Sep 25
1.630
1.640
1.560
1.600
109.7K
29 Aug 25
1.720
1.720
1.611
1.640
106.4K
28 Aug 25
1.850
1.850
1.660
1.700
305.9K
27 Aug 25
1.880
1.880
1.750
1.790
144.5K
26 Aug 25
1.920
1.994
1.820
1.850
168.6K
25 Aug 25
2.030
2.050
1.860
1.900
256.5K
22 Aug 25
2.030
2.052
1.950
1.980
122.7K
21 Aug 25
1.950
2.070
1.870
2.070
123.3K
COMPANY PROFILE
Name:
About:
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Sector:
Healthcare
Industry:
Biotechnology
Address:
2401 4th Avenue, Seattle, WA, United States, 98121
Website:
https://aptevotherapeutics.com
CUSIP:
03835L207
CIK:
0001671584
ISIN:
US03835L2079
FIGI:
BBG009RRZ8C2
LEI:
529900UTQOXOZBMZFN24
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Jan 01, 0001
Purchase Intraday History
for this symbol from Jan 01, 0001
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
Download
FUNDAMENTALS
P/E Ratio:
0.00
Price to Book:
1.00
Price to Sales:
1.61
Shares:
3.29M
Market Cap:
5.56M
TECHNICAL INDICATORS
MA5:
1.68
MA10:
1.82
MA20:
1.95
MA50:
2.58
MA100:
2.35
MA200:
2.89
STO9:
19.15
STO14:
15.00
RSI14:
39.22
WPR14:
-80.85
MTM14:
-0.35
ROC14:
-0.17
ATR:
0.17
Week High:
1.88
Week Low:
1.56
Month High:
2.80
Month Low:
1.56
Year High:
14.90
Year Low:
0.14
Volatility:
8.94
RECENT SPLITS
Date
Ratio
27 May 2025
1-20
04 Dec 2024
1-37
06 Mar 2024
1-44
27 Mar 2020
1-14